PATENT CLAIM ANALYSIS

Application Number: 16292524
Application Type: Utility
Filing Date: 2019-03
Publication Date: 2019-06
Patent Classification: ["514", "228200"]

Abstract:
Substituted fused imidazole derivatives, methods of their preparation, pharmaceutical compositions comprising a substituted fused imidazole derivative, and methods of use in treating conditions or diseases of the eye are provided. The substituted fused imidazole derivatives may control the activity or the amount or both the activity and the amount of heme-oxygenase.

Claim (Index 3):
The method of  claim 2 , wherein X 3  is and X 1 , X 2 , and X 4  are each

Metadata:
- Claim Count in Document: 53.0
- Percentile: 99.0
- Lexical Diversity: 1.64706
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['16007532', '14215873', '13028406', '15584459', '16188652']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8118983850542637
- 35 USC 102 Novelty (BERT): 0.6149326112794707
- Combined Prediction Score: 0.7922018076767844
- Mean Citation Score: 475.68384800000007
- Max Citation Score: 525.9183
- Similarity Product: 519.2638279780091

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test